Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed’s Oral Insulin Capsules

NEW YORK, March 26, 2019 /PRNewswire/ — Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (, a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that its Chinese partner, Hefei Tianhui Incubator of Technologies Co., Ltd. (“HTIT”), has reached the significant regulatory milestone of approval of an investigational new drug application (“IND”) for two […]